about
Sphingolipids and antimicrobial peptides: function and roles in atopic dermatitisCholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and diseaseDetection of host-derived sphingosine by Pseudomonas aeruginosa is important for survival in the murine lungSkin barrier functionAbnormal skin barrier in the etiopathogenesis of atopic dermatitis.Role of keratinocyte injury in adherence of Streptococcus pyogenes.Thematic review series: skin lipids. Antimicrobial lipids at the skin surface.Small-molecule modulators of Listeria monocytogenes biofilm developmentSphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa.Increased incidence of skin infections in atopy: evidence for an antigen-specific homing defect?Stratum corneum defensive functions: an integrated view.Interactions among stratum corneum defensive functions.The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.Sphingoid bases are taken up by Escherichia coli and Staphylococcus aureus and induce ultrastructural damageRole of the calcium-sensing receptor in calcium regulation of epidermal differentiation and functionBasis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanismsResveratrol stimulates sphingosine-1-phosphate signaling of cathelicidin production.Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.Effect of the multifunctional cosmetic ingredient sphinganine on hair loss in males and females with diffuse hair reduction.Altered sphingoid base profiles predict compromised membrane structure and permeability in atopic dermatitisMolecular mechanism for sphingosine-induced Pseudomonas ceramidase expression through the transcriptional regulator SphR.The roles of cutaneous lipids in host defense.Oral mucosal lipids are antibacterial against Porphyromonas gingivalis, induce ultrastructural damage, and alter bacterial lipid and protein compositions.Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis.Therapeutic implications of a barrier-based pathogenesis of atopic dermatitisPhysiological functions and clinical implications of sphingolipids in the gut.Biotechnological production of sphingoid bases and their applications.Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.Immune relevant molecules identified in the skin mucus of fish using -omics technologies.Analysis of ceramide metabolites in differentiating epidermal keratinocytes treated with calcium or vitamin C.Bactericidal activities of milk lipids.Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectivesThe Role of Sphingolipids on Innate Immunity to Intestinal Salmonella Infection.Bronchoalveolar Lavage Microvesicles Protect Burn-Injured Mice from Pulmonary Infection.Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications.Phytosphingosine kills Candida albicans by disrupting its cell membrane.Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents.Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes.Sweat lipid mediator profiling: a noninvasive approach for cutaneous research.
P2860
Q26829596-90FEAE0B-CBE3-4BF2-A881-3EB52D21833BQ26998399-7ED74B30-96C6-438D-BBC7-DA2107E0AE85Q28492560-52CC1451-0297-4F8E-AFC6-15DE2324970CQ33744906-3BD6097E-A3E7-42DA-AED0-6B78B79C7397Q33779047-4E80FAF1-B3B9-4942-9515-EEBB20688754Q34002899-AA59029A-0DF6-4CCD-BCF5-5486050D68F9Q34007240-BCBCB2CF-7B13-4164-BB2E-D2C7080E70F1Q34109642-80DA73FF-F2B4-4BE9-94D3-844832B500ADQ34342508-33DB1370-5EC5-4767-BD8D-6F5C75A03BFAQ34585480-92CB6E74-BE1A-4547-A4AA-11E9E6833EFEQ36228049-743ADEF9-0167-4461-B4C6-67A66C82BA6AQ36263577-8613F611-4701-4C48-B28C-A4CF1D96FC3BQ36587156-64A9EA5A-68F8-4CE9-839D-7919A35FB530Q36790886-F5CD27A0-5976-46C3-9E25-CD0C79BC55D6Q37019151-CC6DBA87-5A04-4728-A6E3-2D674ABC7C8DQ37105441-2278BBA0-B346-49C9-BB26-3B7FA438E4BEQ37120779-85AB7DAB-6AA8-4393-A77D-00A594D2B09DQ37164058-44B9D046-4A50-472C-A76D-398F6EA51F85Q37252350-8A938652-CC24-40F9-8DC3-78D8DEB452F1Q37400951-F9772EFD-DA87-44BC-A45E-260540A95809Q37493639-A3CE1AB2-709B-4249-AECF-1076BFC2F886Q37619216-BCF3ADD6-EC29-4C4C-9FB7-192C32D3BB7DQ37667395-AF719235-1AD9-460E-9CB3-98E4DA7705A2Q37780106-C9255856-3E17-434F-8506-D21E13D1015EQ37822710-404AE1A2-7219-4849-88C5-317343286557Q37852814-071BB576-7F2F-4830-BA53-D40749D56CBAQ38098434-EB9E94ED-DCC9-4AFF-AA9A-B2270FF6C9B0Q38152889-7C5707CB-414C-4CA7-A478-63085BBC119CQ38833190-5441594A-9877-4D5F-96B1-60EBBA110BF0Q39294085-2BC105E1-5CCF-4175-B99A-03C0348708B3Q39477010-606E52AF-65B9-410A-B75F-2BE7CB628EC4Q39556853-FF01C2B8-2383-47EA-9CA6-BE4C29C96D4CQ40104108-441C7F76-EA1A-4C75-A341-B5E7EA7A5F12Q40142535-67DB3663-F572-48EE-B9E6-FF904863B629Q40824179-CF0A6EFD-8C0D-4F96-A438-9F769724039DQ43240514-09F10394-BE7B-432A-B07C-C1FE9D0F6E16Q43674450-2B6D6CE9-3AC8-4CF8-874E-7163AD5F17C8Q44272174-D886469A-AC05-4A8D-ACDA-0CFC2761D794Q44531983-D85A6514-17F6-421B-B4CD-A7E360C7315AQ44594347-AB7113FA-38A2-44B7-B803-635DC15DAF68
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Antimicrobial activity of sphingosines.
@en
Antimicrobial activity of sphingosines.
@nl
type
label
Antimicrobial activity of sphingosines.
@en
Antimicrobial activity of sphingosines.
@nl
prefLabel
Antimicrobial activity of sphingosines.
@en
Antimicrobial activity of sphingosines.
@nl
P2093
P1476
Antimicrobial activity of sphingosines.
@en
P2093
P2888
P304
P356
10.1111/1523-1747.EP12497842
P407
P577
1992-03-01T00:00:00Z
P5875
P6179
1041145178